imiquimod has been researched along with Pemphigoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezdek, S; Guillen, N; Meshrkey, F; Mócsai, A; Mousavi, S; Nimmerjahn, F; Sadik, CD; Seeling, M; Sezin, T; Thieme, M; Wannick, M; Zillikens, D | 1 |
| Cavicchini, S; Gianotti, R; Muratori, S; Vezzoli, P | 1 |
2 other study(ies) available for imiquimod and Pemphigoid
| Article | Year |
|---|---|
Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Topics: Acetic Acid; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aza Compounds; Disease Models, Animal; Fatty Acids, Omega-3; Humans; Imiquimod; Mice; Mice, Inbred C57BL; Pemphigoid, Bullous; Psoriasis; Receptors, G-Protein-Coupled; Treatment Outcome | 2018 |
Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression.
Topics: Adjuvants, Immunologic; Aminoquinolines; Drug Eruptions; Exanthema; Humans; Imiquimod; Immunocompromised Host; Male; Middle Aged; Pemphigoid, Bullous | 2009 |